Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-014490
Filing Date
2004-03-05
Accepted
2004-03-05 11:19:48
Documents
1
Period of Report
2004-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10840
  Complete submission text file 0001209191-04-014490.txt   12816
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 111 W. 57TH STREET SUITE 1100 NEW YORK NY 10019
Business Address 111 W. 57TH STREET SUITE 1100 NEW YORK NY 10019
BROWNE G MORGAN (Reporting) CIK: 0001111363 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 04650836